Diagnostic Imaging Centers of Texas Expanded VoxNeuro Deal
The partnership integrates structural diagnostic imaging with advanced neuroimaging software to assist clinicians.
Updated on Sept. 28, 2026 in Alzheimer’s
Live Poll
Would you trust software analysis results as part of your own medical diagnosis?
Diagnostic Imaging Centers of Texas has expanded its collaboration with VoxNeuro to integrate Cognitive Function Neuroimaging software into its practice. This initiative combines structural imaging with digital analysis to provide clinicians with an objective measure of brain function.
Why it matters
The partnership aims to offer clinicians deeper insights into brain health by pairing diagnostic images with functional data. This objective approach assists providers in evaluating neurological health alongside standard patient history and symptoms.
The integrated software performs a post-hoc statistical analysis of electroencephalograms and event-related potentials. These tools provide objective functional metrics to supplement clinical assessments rather than acting as an independent diagnostic tool.
The players
Diagnostic Imaging Centers of Texas
This network operates in Southeast Texas using the Memorial MRI & Diagnostic and Foundation Physicians Group brands.
VoxNeuro
This technology company develops neuroimaging software that provides objective measures of brain function to clinical providers.
The details
The software suite provides clinicians with a digital analysis of patient electroencephalograms and event-related potentials. Medical providers utilize these objective results to augment their understanding of brain function, weighing findings against traditional imaging, patient history, and reported symptoms.
Timeline
The expanded partnership between the entities was announced on September 28, 2026.
The Big Picture
The partnership follows a pattern set by the FDA-cleared Cognitive Function Neuroimaging framework by standardizing objective functional metrics in a clinical setting. This move represents an industry-wide transition toward integrating multimodal data points to support complex neurological evaluations.
Patients visiting these Texas facilities may now undergo expanded neuroimaging evaluations that supplement traditional scans. This integration allows providers to incorporate objective functional data into their broader diagnostic and treatment decision-making process.
The takeaway
Clinicians must continue to weigh these objective software outputs against comprehensive patient histories and symptom reports. The technology provides a supplementary data point rather than a replacement for professional clinical judgment.
Further reading
Learn more about the latest innovations in Alzheimer’s research and diagnostic tools.
Live Poll
Would you trust software analysis results as part of your own medical diagnosis?
